瘤微环境中的骨髓原抑制细胞 (MDSCs) 和它们在癌症治疗中的向
Shuyan He1, Lu Zheng2, Chunjian Qi3
1Department of Tumor Center, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, Jiangsu, China.
Molecular cancer
|January 9, 2025
概括
骨髓系衍生抑制细胞 (MDSCs) 驱动癌症免疫抑制和瘤进展. 向MDSC可以通过克服瘤免疫逃避并改善患者的治疗结果来提高免疫疗法的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 免疫疗法,包括免疫检查点抑制剂 (ICI),已经改变了癌症治疗.
- 患者对免疫疗法的反应是可变的,通常是由于瘤微环境 (TME) 内的免疫抑制.
- 骨髓原抑制细胞 (MDSC) 是TME中的关键免疫抑制细胞,阻碍了抗瘤免疫力.
研究的目的:
- 审查MDSCs在癌症中的起源,表型和生物学作用.
- 讨论针对MDSCs的当前治疗策略.
- 探索将MDSC向治疗与免疫治疗结合在一起的潜力.
主要方法:
- 对癌症中MDSCs研究的文献综述.
- 对MDSC功能在瘤进展和免疫逃避中的分析.
- 检查涉及MDSCs和免疫治疗的治疗方法和组合策略.
主要成果:
- MDSCs抑制抗瘤免疫反应,促进癌症的生长,转移和血管生成.
- 通过产生免疫抑制性TME,MDSCs有助于免疫疗法耐药性.
- 针对MDSC是一个有希望的策略,可以提高癌症治疗效率.
结论:
- MDSCs是瘤免疫反应的关键调节者,是可行的治疗标.
- 将MDSC向疗法与免疫疗法相结合具有改善癌症治疗结果的巨大潜力.
- 对MDSC生物学和有针对性的干预措施的进一步研究对于推进癌症治疗至关重要.
更多相关视频
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
22.4K
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.4K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
